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Abstract
Scrapie in sheep and new variant Creutzfeldt-Jakob disease in humans are typically initiated by extracere-
bral exposure to prions. Both exhibit early prion accumulation in sites of the peripheral lymphoreticular system,
such as splenic or lymph nodal germinal centers. In germinal centers, follicular dendritic cells (FDCs), whose
development and maintenance depend on lymphotoxin and tumor necrosis factor signaling, are believed to be
the main cell type for efficient prion replication in the periphery. Here, we discuss the molecular requirements
for prion replication competence in stromal and lymphoid compartments of lymphoid organs. In addition,
we examine the preconditions of transepithelial passage of prions in the mucosal-associated lymphoid system.
Our results suggest that under specific conditions, efficient prion replication in mesenteric and inguinal lymph
nodes is possible in the absence of mature FDCs. M cells are a plausible candidate for the mucosal portal of
prion infection.
Index Entries: Immune system; prions; follicular dendritic cells (FDCs); lymphotoxin (LT); tumor necrosis
factor (TNF).
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Introduction
Prion diseases are lethal, transmissible, neurode-
generative conditions. The causative agent was pro-
posed to be identical with prion protein (PrP)Sc, a
pathological conformer of the cellular protein PrPC
encoded by the cellular gene Prnp (Prusiner, 1982).
PrPC is expressed in many sites, notably including
secondary lymphoid organs. Peripheral inoculation
routes are likely to initiate most forms of spongiform
encephalopathies such as sheep scrapie, bovine
spongiform encephalopathy (BSE), iatrogenic
Creutzfeldt-Jakob disease (iCJD) and variant CJD
(vCJD). Also, intracerebral (ic) or peripheral admin-
istration of prions to mice induces a rise of infectiv-
ity in spleen and in other lymphoid organs long
before the development of neurological symptoms
and neuropathological changes. Intraperitoneal (ip)
inoculation has been used extensively to study the
pathogenesis of transmissible spongiform
encephalopathies because it causes rapid accumu-
lation of infectivity in secondary lymphoid organs
(Clarke and Haig, 1970; Hill et al., 1997; Hilton et al.,
1998). The question of which compartments within
lymphoreticular tissues support prion replication is
of relevance to public health: Contamination with
vCJD prions of germinal centers in lymph nodal and
tonsillar follicles, for example, might call for pre-
cautionary measures in the handling and steriliza-
tion of surgical instruments. Also in sporadic CJD
(sCJD), prions appear to be much more prevalent in
extracerebral tissues than previously appreciated
(Glatzel et al., 2003).
Tumor necrosis factor (TNF) and homotrimeric
lymphotoxinα (LTα) signal through TNFR1, whereas
membrane-bound LTα/β heterotrimers signal
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through LTβR (Ware et al., 1995) (Fig. 1). TNFR1 and
LTβR signaling is necessary for development and
maintenance of secondary lymphoid organs
(Rennert et al., 1996; Koni et al., 1997; Korner et al.,
1997; Futterer et al., 1998) and their proper micro-
architecture. LTβR signaling is also required for
maturation and maintenance of follicular dendritic
cells (FDCs), which are thought to be essential for
prion replication and for accumulation of disease-
associated PrPSc within secondary lymphoid organs.
Inhibition of the LTβ signaling pathway with a sol-
uble receptor, which depletes FDCs (Mackay and
Browning, 1998), abolishes prion replication in
spleens and prolongs the latency of scrapie after ip
challenge (Montrasio et al., 2000). B-cell-deficient
µMT mice (Kitamura et al., 1991) are resistant to
prions ip (Klein et al., 1997), most likely because
of impaired FDC maturation (Klein et al., 1998;
Montrasio et al., 2001). Accordingly, the relative dis-
tance between FDCs and splenic nerves controls the
velocity of prion neuroinvasion (Prinz et al., 2003a).
In addition to FDCs, PrPC-expressing hematopoietic
cells are required for efficient lymphoreticular prion
propagation (Kaeser et al., 2001).
In recent years we have studied peripheral prion
pathogenesis in mice lacking TNFα, LTα/β, or their
receptors. We found that ablation of LTβR signaling
prevents peripheral pathogenesis (Montrasio et al.,
2000; Prinz et al., 2002), whereas ablation of TNFR1
signaling prevents prion pathogenesis in spleen but
not in lymph nodes, despite the absence of FDCs.
Moreover we have investigated some of the pre-
conditions of transepithelial passage of prions, iden-
tifying M cells as a plausible candidate for the
mucosal portal of prion infection.
Lymphoid Microarchitecture
and Efficient Peripheral Prion Replication
Even though FDCs are believed to be the key cell
type for efficient prion replication, mice devoid of
mature FDCs did show prion titers in secondary lym-
phoid organs? The absence of TNFR1 and TNFα pre-
served susceptibility to peripheral prion challenge,
whereas deletion of LT signaling components
confers high resistance to peripheral prion infection,
as detected by Western blot analysis and transmis-
sion experiments into tga20 indicator mice (Fig. 2).
Fig. 1. Schematic drawing of signals provided by mature
B cells essential for maturation and maintenance of FDCs.
Membrane-bound LTα1/β2 heterotrimers expressed on B cells
signal through LTβR expressed on mature FDCs. Soluble
homotrimeric LTα3 and TNFα3 secreted by B cells signal
through TNFR1 expressed on mature FDCs.
Fig. 2. (see opposite page) Western blot analysis of brains and spleens, as well as determination of prion infectivity
titers in spleens and lymph nodes, of scrapie-challenged TNF- and LT-deficient mice. (A,B) Western blots of brain mater-
ial electrophoresed natively (–), or after digestion with proteinase K (PK) (+). Large amounts of PK-resistant prion protein
(PrPSc) were detected in the brain of all mice that had developed scrapie (terminal sick), independently of the genotype.
Clinical healthy mice deficient in LT signaling showed no PrPSc accumulation, excluding subclinical scrapie (A).
(C) Western blots of spleen homogenates electrophoresed natively (–) or after digestion with proteinase K (+). TNFR1–/–
and TNFα–/– mice accumulated lower amounts of PrPSc as compared to TNFR2–/– and wild-type mice. No PrPSc was detected
in the spleens of clinical healthy LT-deficient mice. (D) Prion infectivity in lymphoid organs. Titers were determined in
spleens (dark circles, •), inguinal (light circles, •), mesenteric (crosses, X), and cervical (triangles) lymph nodes at the
time points indicated below the graphs. Mice were inoculated ip with 6 logLD50 or 4 logLD50 of scrapie prions as indi-
cated. Standard deviations within groups are drawn only when exceeding ±0.75 logLD50. (a,b) In each of two separate
transmissions, 1 out of 4 tga20 mice died 24 h after inoculation, probably because of intracerebral bleeding after injec-
tion. (j,k) Intercurrent death during incubation time. Symbols on the abscissa indicate prion titers below detection limit
(none of the four indicator mice developed scrapie). If one or more indicator mice survived <180 dpi, or the mean incu-
bation time was >120 d, titer was assumed to be close to the detection threshold of the bioassay. For these Fig. 2. (con-
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tinued) samples (labeled with lowercase letters) the numbers of animals succumbing to scrapie out of four inoculated
tga20 mice and incubation time (in days) to terminal scrapie were as follows: (c) 1/4 (111), (d) 3/4 (93, 117, 132), (e) 2/4
(90, 95), (f) 1/4 (126), (g) 3/4 (112, 123, 128), (h) 4/4 (106, 115, 124, 136), (i) 3/4 (89, 102, 119), (l) 4/4 (115, 115, 126,
135), (m) 1/4 (98), (n) 2/4 (74, 78), (o) 2/4 (125, 151), (p) 2/4 (131, 193), (q) 3/4 (119, 125, 152), (r) 2/4 (109, 117), (s) 1/4
(108), (t) 1/4 (71) (u) 3/4 (80, 96, 98).( v ) 2/4 (98, 98).
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These differential effects on scrapie susceptibility
were surprising, as all of these defects (except
TNFR2–/–) abolish FDCs, which were thought to be
crucial for pathogenesis. However, LT/TNF family
members play distinct roles in lymph node induc-
tion and development (Fu and Chaplin, 1999):
Lymphoid organ architecture, including organiza-
tion of T and B cell zones, is more severely impaired
in LT- than in TNF-deficient mice (Fu and Chaplin,
1999). Because LT and TNF signaling defects might
potentially affect several immune cell lineages, we
have performed additional adoptive fetal liver cell
transfer studies that complement the gene ablation
experiments.
In Prnp0/0 mice grafted with TNFR1–/– fetal liver
cells (FLCs), high infectivity loads (3.4–4.2 logLD50)
were detectable in lymph nodes but not spleens,
strongly indicating a role of TNFR1-deficient
hematopoietic cells in efficient prion propagation
within lymph nodes. Conversely, lymph nodes of
TNFR1–/– mice grafted with Prnp0/0 FLCs contained
substantial amounts of infectivity. Therefore,
stromal cells also contribute to the capability of
TNFR1–/–-deficient lymph nodes to replicate prions.
Reciprocal reconstitution of wild-type and Prnp0/0
mice showed once again that efficient lymphoretic-
ular prion propagation required PrPC expression in
both stromal and hematopoietic compartments
(Blättler et al., 1997; Kaeser et al., 2001).
These results imply that prion replication can take
place in secondary lymphoid organs even in the
absence of mature FDCs and that other cell types can
maintain replication of prions to titers that are sim-
ilar to those of wild-type mice. Moreover, prion
pathogenesis in the lymphoreticular system can be
topographically compartmentalized, and lymph
nodes can represent an important reservoir of prion
infectivity during disease.
This hypothesis is strengthened by the fact that
even in wild-type lymph nodes, bright PrP signals
outside FDC networks colocalized with a subset of
ER-TR9- and MOMA-1-positive cells (Prinz et al.,
2002).
TNFα signaling through TNFR1 is required for
proper homing of macrophages to the splenic mar-
ginal zone, and their absence can cause strong aber-
rations in macrophage subsets. However, MOMA-1+
and ER-TR9+ macrophages were normally distrib-
uted in the subcapsular area of TNFR1–/– and
TNFα–/– lymph nodes (Pasparakis et al., 2000) but
were strongly disturbed in mesenteric lymph nodes
of LTβ–/– mice. It was suggested that FDC precursor
cells in TNFR1–/– mice could be located in the ger-
minal center marginal zone and could interact with
macrophages there. In addition, this study showed
that to the defects in follicular structure, TNFR1–/–
mice exhibit defects in the formation of the splenic
but not the lymph node macrophage populations,
which is in contrast to all LT knockout mice. The
investigators concluded that the primary defect in
the lymphoid phenotype of TNFR1–/– mice is the
failure of possible FDC precursors to migrate through
the disorganized marginal sinus and to home prop-
erly into the lymph node follicular areas where they
would promote the formation of B-cell follicles and
germinal centers (Pasparakis et al., 2000).
If the distribution of macrophages is important
for peripheral prion pathogenesis, these histoarchi-
tectural differences might account for the differences
in splenic versus lymph nodal prion load of infected
TNFR1–/– and TNFα–/– mice. Primary and secondary
follicles might be functionally different in spleen vs
mesenteric lymph nodes of TNFR1–/– mice (Fu et al.,
1997). However, we did not identify morphological
differences between splenic and mesenteric germi-
nal centers, and the TNFR1–/– line used here (Rothe
et al., 1993) did not show abnormal germinal center
responses after infection with vesicular stomatitis
virus (Karrer et al., 2000).
As described repeatedly (Klein et al., 1997; Kaeser
et al., 2001; Prinz et al., 2002), B-cell-deficient mice
were entirely resistant to ip-administered prions,
whereas TNF/LT-deficient mice were partially resis-
tant. These findings differ from those reported by
Mabbott and colleagues (2000) and suggest that the
importance of B lymphocytes in prion pathogenesis
might go beyond their role in FDC maintenance.
The unexpected finding of high prion titers in
inguinal, mesenteric, and cervical lymph nodes of
TNF-deficient—but not in mesenteric lymph nodes
of LTβ-deficient—mice indicates that prion replica-
tion within secondary lymphoid organs is LTβR
dependent yet may occur in the absence of mature
FDCs and functional germinal centers.
Therefore, cell types other than mature FDCs par-
ticipate in the process of prion replication/accu-
mulation in lymph nodes and, probably, in spleens.
Because marginal zone macrophages might enter-
tain close contacts to immature FDCs in the mar-
ginal zone, whose presence was postulated for the
TNFR1–/– mice (Pasparakis et al., 2000), and also
interact with marginal zone B cells, this cell type is
certainly a candidate for supportive effects in the
process of prion uptake and replication.
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However, this interpretation has one caveat:
Immunofluorescence detects PrP rather than infec-
tivity and does not differentiate unequivocally
between PrPC and PrPSc. Therefore, further studies
will need to focus on whether macrophage ablation,
that is, using macrophage-specific suicide trans-
genes, can suppress the infectibility of TNF-deficient
lymph nodes.
Moreover, these findings are at striking variance
with reports that LTβ–/– mice are fully susceptible to
infection with CJD prions (Rothe et al., 1993) and
that TNFα–/– mice peripherally challenged with ME7
prions are largely protected (Mabbott et al., 2000).
These and other discrepancies have been attributed
to the use of different prion strains in these studies.
This may well be the case, but our results indicate
that resistance in each mouse strain is dose depen-
dent and can always be overridden. Therefore, chal-
lenge with one single size of inoculum, as done in
other studies, might yield misleading results.
Invasion of lymphoid organs by prions occurs
very rapidly after peripheral inoculation, and con-
sistently high infectivity titers are detected until ter-
minal disease. Lymphoinvasion most likely plays an
important role in the pathogenesis of vCJD, as prion
infectivity can be detected in the tonsils of virtually
every vCJD patient (Bruce et al., 2001; Wadsworth
et al., 2001). After lymphoinvasion, neuroinvasion
occurs via autonomic nerves (Cole and Kimberlin,
1985; Race et al., 2000; Glatzel et al., 2001), but the
nexus between germinal centers and nerves is still
elusive. By virtue of their mobility, macrophages
may represent a plausible candidate for transport of
prion infectivity from germinal centers to sympa-
thetic nerve terminals.
How could a possible prion amplification in
macrophages be reconciled with their apparent pro-
tective role, at least in the very early phase of prion
pathogenesis (Beringue et al., 2000)? Maybe the
action of macrophages is dose dependent: Small inoc-
ula might be destroyed by phagocytosis, whereas
larger inocula cannot be digested and will be trans-
ported or amplified. Alternatively, the absence of
TNFR1 might interfere directly with the interaction
of macrophages and prions, as ablation of TNF sig-
naling reduces the phagocytic ability of macrophages
in several infectious models (Yap et al., 1998). Nev-
ertheless, the fact that a cell type other than mature
FDCs is involved in prion replication and accumu-
lation within secondary lymphoid organs might help
to develop postexposure prophylaxis strategies
aimed at blocking prion neuroinvasion.
The Pathway of Orally
Administered Prions
Upon oral challenge, an early rise in prion infec-
tivity can be observed in the distal ileum of infected
organisms: This applies to several species but was
investigated most extensively in sheep ( Wells et al.,
1994; van Keulen et al., 1999). There, Peyer’s patches
(PPs) acquire strong immunopositivity for the PrP.
Immunohistochemical stains with antibodies to the
PrP typically reveal a robust signal in primary B-cell
follicles and germinal centers, which roughly colo-
calizes with the complement receptor CD35 in a wide
variety of secondary lymphoid organs, including
appendix and tonsils (Hill et al., 1997). Although
conventional light microscopy does not allow dif-
ferentiation between PrPC and PrPSc, Western blot
analysis has not left any doubt about the fact that
PPs do accumulate the disease-associated form of
the PrP.
The latter is true also in the mouse model of
scrapie, which is being used as a convenient exper-
imental paradigm by many laboratories, including
ours. Administration of mouse-adapted scrapie
prions (Rocky Mountain Laboratory or RML strain,
originally derived from the Chandler sheep scrapie
isolate) induces a surge in intestinal prion infectivity
as early as a few days after inoculation (Prinz et al.,
2003b).
All of the above evidence conjures the suggestion
that PPs might represent a portal of entry for orally
administered prions on their journey from the lumi-
nal aspect of the gastroenteric tube to the central ner-
vous system. However, the question as to whether
the same applies to BSE-affected cattle has been
answered less definitely.
In a monumental study of BSE pathogenesis in
cattle, carried out at the UK Veterinary Laboratory
Agency, cows of various ages were fed with 100 g,
10 g, 1 g, or 100 mg of brain homogenate derived
from BSE-sick cows (Bradley, 2000). A large variety
of tissues were taken at various points in time, homog-
enized, and transmitted ic to indicator to assess their
prion content. This study was designed to be per-
formed over a time frame of more than a decade and
was still under way at the time of this writing: It has
uncovered a transient surge in infectivity in the
distal ileum of cows at approx 6 mo postinfection.
Infectivity then subsides, but it appears to return to
the terminal ileum at the end stages of disease,
maybe by means of some sort of retrograde trans-
port (Wells et al., 1998). Although this was not
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formally confirmed, it appears likely that PPs are the
sites of prion accumulation in the gastrointestinal
tract of cattle challenged orally with prions.
Transepithelial Enteric Passage of Prions:
A Role for M Cells?
We have set out to investigate some of the pre-
conditions of transepithelial passage of prions.
Membranous epithelial cells (M cells) are key sites
of antigen sampling for the mucosal-associated lym-
phoid system (MALT) and have been recognized as
major ports of entry for enteric pathogens in the gut
via transepithelial transport (Neutra et al., 1996).
Interestingly, maturation of M cells is dependent on
signals transmitted by intraepithelial B cells. The
group of Jean-Pierre Kraehenbuhl (Lausanne) has
developed efficient in vitro systems, in which epithe-
lial cells can be instructed to undergo differentia-
tion to cells that resemble M cells by morphological
and functional–physiological criteria (Kerneis et al.,
1997). Therefore, we investigated whether M cells
are a plausible site of prion entry in a coculture
model (Kerneis et al., 1997) (Fig. 3). Colon carcinoma
cells (line Caco-2) were seeded on the upper face of
transwell filters and cultured until confluency was
reached. Next, B-lymphoblastoid Raji cells were
added onto the lower side of the filters. Lymphoid
cells migrated through the pores of the filter and
settled within the epithelial monolayer, inducing
differentiation of some Caco-2 cells into M cells. Suc-
cessful conversion was monitored by measuring
transport of fluorescein-conjugated latex beads in
cocultures that exhibited a high transepithelial resis-
tance and were therefore tight. Active transepithe-
lial transport of beads, but not passive leakage, was
blocked at 4°C. Scrapie prions were administered
to the apical compartment of cocultures that com-
bined integrity and active transport of beads. After
24 h, infectivity was determined within the baso-
lateral compartment by bioassay with tga20 mice,
which overexpress a Prnp transgene and develop
scrapie rapidly after infection (Fischer et al., 1996).
Upon challenge with 5 logLD50 of scrapie prions,
we consistently recovered prions in the basolateral
compartment of cocultures containing M cells, sug-
gesting transepithelial prion transport. Even at low
prion doses (3 logLD50), we found infectivity in at
least one M-cell-containing coculture. In contrast,
there was hardly any prion transport in Caco-2 cul-
tures without M cells (Heppner et al., 2001) (Fig. 3).
These findings indicate that M-cell differentia-
tion is necessary and sufficient for active trans-
epithelial prion transport in vitro.  M-cell-dependent
uptake of foreign antigens or particles is known to
be followed by rapid transcytosis directly to the
intraepithelial pocket, where key players of the
immune system, for example, macrophages, den-
dritic cells, and lymphocytes (Neutra et al., 1996),
are located. It has been shown that immune cells
are crucially involved in the process of neuroinva-
sion and that (as suspected) mature FDCs, located
in the PP, are critical for the transmission of scrapie
from the gastrointestinal tract (Aguzzi and Heppner,
2000; Mabbott et al., 2003). Therefore, prions might
exploit M-cell-dependent transcytosis to gain access
to the immune system.
Although these findings suggest that M cells are
a plausible candidate for the mucosal portal of prion
infection, it still remains to be established whether
the pathway delineated above does indeed repre-
sent the first portal of entry of orally administered
prions into the body. This will necessitate in vivo exper-
imentation, that is, by ablation of M cells through
suicide transgenetic strategies, or by M-cell-specific
expression of Prnp transgenes. Results of such
experiments might help to define specific thera-
peutic strategies to prevent prions from entering the
immune system after oral uptake.
To this effect, it is interesting to note that a dimeric
fusion protein composed of two immunoglobulin
Fcγ domains fused to two PrPC molecules (PrP-Fc2
fusion protein) prolongs the latency period of prion
infection upon expression in transgenic mice by com-
peting with PrPC for PrPSc (Meier et al., 2003). This
highly stable, soluble, dimeric fusion protein might
serve as an effective antiprion therapeutic acting at
the site of uptake, in the periphery, or even in the
brains of infected individuals.
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